10x Genomics (TXG) Stock Trades Down, Here Is Why [Yahoo! Finance]
10x Genomics, Inc. (TXG)
Last 10x genomics, inc. earnings: 2/18 04:01 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Shares of biotech company 10x Genomics (NASDAQ:TXG) fell 2.4% in the afternoon session after the stock extended its negative momentum as Piper Sandler initiated coverage of the stock with a Neutral rating and a $15.00 price target. While the research firm acknowledged that 10x Genomics has a leading offering in the single-cell market with significant technological advantages, it expressed concerns about the company's near-term performance. The primary issue cited was ongoing price compression within the market. Piper Sandler recommended that investors wait for the company to navigate the current macroeconomic environment before investing. This cautious outlook suggests potential headwinds, as the firm also noted that the related spatial market may take several years to fully develop, tempering enthusiasm for the stock's immediate growth prospects. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to
Show less
Read more
Impact Snapshot
Event Time:
TXG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TXG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TXG alerts
High impacting 10x Genomics, Inc. news events
Weekly update
A roundup of the hottest topics
TXG
News
- 10x Genomics (NASDAQ:TXG) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending [Yahoo! Finance]Yahoo! Finance
- 10x Genomics (NASDAQ:TXG) had its price target raised by analysts at Canaccord Genuity Group Inc. from $19.00 to $20.00. They now have a "buy" rating on the stock.MarketBeat
- 10x Genomics (NASDAQ:TXG) had its "overweight" rating reaffirmed by analysts at Barclays PLC.MarketBeat
- 10x Genomics (NASDAQ:TXG) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "cautious" rating.MarketBeat
TXG
Earnings
- 11/6/25 - Beat
TXG
Sec Filings
- 11/25/25 - Form 4
- 11/25/25 - Form 4
- 11/25/25 - Form 4
- TXG's page on the SEC website